Emerald Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $773K | Sell |
|
|||||
|
2025
Q2 | $633K | Buy |
|
|||||
|
2025
Q1 | $404K | Sell |
|
|||||
|
2024
Q4 | $372K | Buy |
|
|||||
|
2024
Q3 | $434K | Sell |
|
|||||
|
2024
Q2 | $393K | Sell |
|
|||||
|
2024
Q1 | $309K | Sell |
|
|||||
|
2023
Q4 | $401K | Sell |
|
|||||
|
2023
Q3 | $535K | Sell |
|
|||||
|
2023
Q2 | $586K | Sell |
|
|||||
|
2023
Q1 | $627K | Buy |
|
|||||
|
2022
Q4 | $608K | Sell |
|
|||||
|
2022
Q3 | $520K | Sell |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $479K | Sell |
|
|||||
|
2021
Q4 | $507K | Sell |
|
|||||
|
2021
Q3 | $572K | Sell |
|
|||||
|
2021
Q2 | $693K | Hold |
|
|||||
|
2021
Q1 | $577K | Sell |
|
|||||
|
2020
Q4 | $555K | Sell |
|
|||||
|
2020
Q3 | $1.11M | Sell |
|
|||||
|
2020
Q2 | $1.15M | Sell |
|
|||||
|
2020
Q1 | $999K | Sell |
|
|||||
|
2019
Q4 | $1.07M | Sell |
|
|||||
|
2019
Q3 | $858K | Sell |
|
|||||
|
2019
Q2 | $883K | Sell |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $961K | Sell |
|
|||||
|
2018
Q3 | $1.59M | Buy |
|
|||||
|
2018
Q2 | $1.75M | Buy |
|
|||||
|
2018
Q1 | $1.65M | Sell |
|
|||||
|
2017
Q4 | $1.89M | Sell |
|
|||||
|
2017
Q3 | $1.86M | Sell |
|
|||||
|
2017
Q2 | $1.38M | Sell |
|
|||||
|
2017
Q1 | $1.9M | Sell |
|
|||||
|
2016
Q4 | $1.39M | Sell |
|
|||||
|
2016
Q3 | $2.91M | Buy |
|
|||||
|
2016
Q2 | $2.22M | Buy |
|
|||||
|
2016
Q1 | $1.6M | Buy |
|
|||||
|
2015
Q4 | $2.16M | Sell |
|
|||||
|
2015
Q3 | $2.45M | Sell |
|
|||||
|
2015
Q2 | $5.17M | Sell |
|
|||||
|
2015
Q1 | $5.42M | Sell |
|
|||||
|
2014
Q4 | $24.3M | Sell |
|
|||||
|
2014
Q3 | $23.6M | Sell |
|
|||||
|
2014
Q2 | $19.6M | Buy |
|
|||||
|
2014
Q1 | $19.9M | Sell |
|
|||||
|
2013
Q4 | $20M | Sell |
|
|||||
|
2013
Q3 | $24.5M | Sell |
|
|||||
|
2013
Q2 | $12.1M | Buy |
|